“…[1][2][3][4][5] Despite the survival benefits of CF-LVAD therapy, a significant proportion of patients develop perioperative complications, mainly due to right ventricular dysfunction (RVD) or right ventricular failure (RVF) after CF-LVAD placement. [1][2][3][4][5][6] RVD/RVF occurrence may be secondary to changes in the geometry and function of the right ventricle induced in part by the LVAD (increased circulatory volume and excessive left ventricular decompression) and fluid management and may result in low CF-LVAD output, right heart failure, and multisystem organ failure. 2,4 Unfortunately, when RVF develops, treatment using mechanical circulatory support, pulmonary vasodilators, fluid restriction, and inotropes may not restore right ventricular (RV) function, and poor short-and long-term outcomes may ensue.…”